How effective are opioids in relieving neuropathic pain

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Pain Clinic

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1163/156856902320761360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathobiology of neuropathic pain.

  2001cited by this paper
• Morphine-induced Spinal Release of Adenosine Is Reduced in Neuropathic Rats

  2001cited by this paper
• Opioid formulations: tailoring to the needs in chronic pain

  2001cited by this paper
• Opioids in non‐cancer pain: a life‐time sentence?

  2001cited by this paper
• Opioids in chronic pain.

  2001cited by this paper
• Advances in the Diagnosis and Management of Peripheral Nerve Disease

  2001cited by this paper
• NMDA receptors as targets for drug action in neuropathic pain.

  2001cited by this paper
• Attenuation of μ-Opioid Tolerance and Cross-Tolerance by the Competitive N-Methyl-d-aspartate Receptor Antagonist LY235959 Is Related to Tolerance and Cross-Tolerance Magnitude

  2000cited by this paper
• Wind‐up and the NMDA receptor complex from a clinical perspective

  2000cited by this paper
• Managing chronic nonmalignant pain: Overcoming obstacles to the use of opioids

  2000cited by this paper
• Morphine with dextromethorphan: conversion from other opioid analgesics.

  2000cited by this paper
• Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist

  2000cited by this paper
• NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance.

  2000cited by this paper
• Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury.

  2000cited by this paper
• Guanosine and GMP prevent seizures induced by quinolinic acid in mice.

  2000cited by this paper
• The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.

  2000cited by this paper
• Spinal and Supraspinal Mechanisms of Neuropathic Pain

  2000cited by this paper
• Abuse potential of morphine/dextromethorphan combinations.

  2000cited by this paper
• Wind-up of spinal cord neurones and pain sensation: much ado about something?

  2000cited by this paper
• Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study.

  2000cited by this paper
• Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions.

  1999cited by this paper
• Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache.

  1999cited by this paper
• Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

  1999cited by this paper
• Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators.

  1999cited by this paper
• Are opioids effective in relieving neuropathic pain?

  1999cited by this paper
• Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.

  1999cited by this paper
• Lamotrigine may limit pathological excitation in the hippocampus by modulating a transient potassium outward current.

  1998cited by this paper
• Dextromethorphan potentiates the effect of morphine in rats with peripheral neuropathy

  1998cited by this paper
• Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.

  1998cited by this paper
• Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine?

  1998cited by this paper
• Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists.

  1998cited by this paper
• ATP and glutamate are released from separate neurones in the rat medial habenula nucleus: frequency dependence and adenosine‐mediated inhibition of release

  1998cited by this paper
• Adenosine receptor activation and nociception.

  1998cited by this paper
• ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.

  1998cited by this paper
• Adenosine for pain control

  1997cited by this paper
• Glutamate: a role in normal brain function, anaesthesia, analgesia and CNS injury.

  1997cited by this paper
• Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain.

  1997cited by this paper
• High‐dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

  1997cited by this paper
• Windup and central sensitization are not equivalent.

  1996cited by this paper
• Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum

  1996cited by this paper
• Randomised trial of oral morphine for chronic non-cancer pain.

  1996cited by this paper
• Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications.

  1996cited by this paper
• Adenosine modulates N-methyl-D-aspartate-stimulated hippocampal nitric oxide production in vivo.

  1995cited by this paper
• N-methyl-d-aspartate receptors and pain

  1995cited by this paper
• Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan.

  1995cited by this paper
• Long-term intraspinal infusions of opioids in the treatment of neuropathic pain.

  1995cited by this paper
• Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization.

  1995cited by this paper
• Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.

  1995cited by this paper
• Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms

  1994cited by this paper
• Relief of post‐herpetic neuralgia with the Symbol receptor antagonist ketamine: A double‐blind, cross‐over comparison with morphine and placebo

  1994cited by this paper
• Pharmacology of chronic pain.

  1994cited by this paper
• The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests

  1994cited by this paper
• Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin.

  1993cited by this paper
• Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence

  1993cited by this paper
• Adenosine A1 Receptor Inhibition of Glutamate Exocytosis and Protein Kinase C‐Mediated Decoupling

  1993cited by this paper
• Opioid sensitivity of chronic pain: a patient‐controlled analgesia method

  1992cited by this paper
• The effect of ritanserin on treatment-resistant neuroleptic induced akathisia: case reports.

  1992cited by this paper
• Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia.

  1992cited by this paper
• Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation

  1992cited by this paper
• Evidence-based medicine. A new approach to teaching the practice of medicine.

  1992cited by this paper
• Painful neuropathy: altered central processing maintained dynamically by peripheral input

  1992cited by this paper
• The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn.

  1992cited by this paper
• Adenosine release in morphine-induced hypotension in rats.

  1992cited by this paper
• The quantitative autoradiographic distribution of [3H]MK-801 binding sites in the normal human spinal cord.

  1991cited by this paper
• A call for more science, not more rhetoric, regarding opioids and neuropathic pain.

  1991cited by this paper
• Intracerebroventricular morphine releases adenosine and adenosine 3',5'-cyclic monophosphate from the spinal cord via a serotonergic mechanism.

  1991cited by this paper
• Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat.

  1991cited by this paper
• Opioid-responsive and opioid-non-responsive pain in cancer.

  1991cited by this paper
• Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain

  1991cited by this paper
• Excitatory amino acids and synaptic transmission: the evidence for a physiological function.

  1990cited by this paper
• The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

  1990cited by this paper
• Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches.

  1990cited by this paper
• Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.

  1989cited by this paper
• Nociceptive nerve pain and neuropathic pain.

  1989cited by this paper
• Excitatory amino acid receptors in the human cerebral cortex: a quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine, L-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites.

  1989cited by this paper
• Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain

  1988cited by this paper
• Long‐term use of narcotic/antidepressant medication in the management of phantom limb pain

  1986cited by this paper
• Chronic use of opioid analgesics in non‐malignant pain: Report of 38 cases

  1986cited by this paper
• Differential Effects of Epidural Morphine in the Treatment of Cancer‐related Pain

  1985cited by this paper

• Recent Developments in the Management of Post- Traumatic Pain

  2010cites this paper
• The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.

  2009cites this paper
• Phantom limb pain induced by spinal anesthesia.

  2005cites this paper
• Neuropathic low back pain

  2005cites this paper
• Evidence-based practice guidelines for interventional techniques in the management of chronic spinal pain.

  2003cites this paper
• The Evolution of Interventional Pain Management An Historical Review

  2003cites this paper